Holen Sie sich die Stockscreener-App
5.86
3.14%
-0.19
Finanzdaten der Terns Pharmaceuticals Inc-Aktie (TERN)
Gewinn- und Verlustrechnung
Vierteljährlich
*Alle Zahlen in Millionen
| Enddatum des Zeitraums | 2024-03-31 | 2023-12-31 | 2023-09-30 | 2023-06-30 | 2023-03-31 |
| Periodenlänge | 3 Monate | 3 Monate | 3 Monate | 3 Monate | 3 Monate |
| Revenues |
-
|
- | - | - | - |
| Costs And Expenses |
5.77%
25.45
|
24.06 | 33.18 | 21.16 | 24.16 |
| Operating Income/Loss |
5.77%
-25.45
|
-24.06 | -33.18 | -21.16 | -24.16 |
| Nonoperating Income/Loss |
2.66%
3.17
|
3.088 | 3.475 | 3.335 | 2.689 |
| Income/Loss From Continuing Operations Before Tax |
6.23%
-22.28
|
-20.97 | -29.71 | -17.82 | -21.47 |
| Income Tax Expense/Benefit |
97.96%
0.097
|
0.049 | 0.058 | 0.072 | 0.06 |
| Income/Loss From Continuing Operations After Tax |
6.44%
-22.37
|
-21.02 | -29.77 | -17.90 | -21.53 |
Net Income/Loss
|
6.44%
-22.37
|
-21.02 | -29.77 | -17.90 | -21.53 |
| Preferred Stock Dividends And Other Adjustments |
-
|
- | - | - | - |
| Attributable To Noncontrolling Interest |
-
|
- | - | - | - |
| Basic Average Shares |
20,457%
74.40
|
0.3619 | 71.53 | 71.36 | 69.78 |
| Diluted Average Shares |
20,457%
74.40
|
0.3619 | 71.53 | 71.36 | 69.78 |
| Basic Earnings Per Share |
3.45%
-0.30
|
-0.29 | -0.42 | -0.25 | -0.31 |
| Diluted Earnings Per Share |
3.45%
-0.30
|
-0.29 | -0.42 | -0.25 | -0.31 |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic |
-
|
- | - | - | - |
2.88%
2.65%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):